Veranova A CDMO that manages complexity with confidence

Veranova A CDMO that manages complexity with confidence

X

Digital content for Mundipharma

Mundipharma

MUNDIPHARMA

About, Contact Details

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

No Presentations

VIDEO(s)

No Video

DIGITAL CONTENT

91 News

91 News

APIs // Active Pharmaceutical Ingredients

1 APIs, 1 USDMF

DEVELOPMENTS

13 Drug(s) in Development

13 Drug(s) in Development

DOSSIERs // Finished Dosage Formulations

348 Dossiers, 159 Europe, 148 Australia, 41 South Africa

INSPECTIONS & REGISTRATIONS

3 FDA, 1 GDUFA

Full View Screen

Full Screen View

EMA Accepts Rezafungin MAA for the Treatment of Invasive Candidiasis

EMA Accepts Rezafungin MAA for the Treatment of Invasive Candidiasis

BUSINESSWIRE

22 Aug 2022

Mundipharma and Cidara report positive PIII results into candidemia treatment

Mundipharma and Cidara report positive PIII results into candidemia treatment

PHARMAFILE

26 Apr 2022

Mundipharma and Cidara Therapeutics Announce First Presentation of Results

Mundipharma and Cidara Therapeutics Announce First Presentation of Results

BUSINESSWIRE

25 Apr 2022

Cidara, Mundipharma to Present Results from Global Phase 3 Trial of Rezafungin

Cidara, Mundipharma to Present Results from Global Phase 3 Trial of Rezafungin

GLOBENEWSWIRE

14 Apr 2022

Cidara, Mundipharma Show +ve Topline Results from Phase 3 Trial of Rezafungin

Cidara, Mundipharma Show +ve Topline Results from Phase 3 Trial of Rezafungin

BUSINESSWIRE

14 Dec 2021

Cidara and Mundipharma Announce Completion of Phase 3 Trial of Rezafungin

Cidara and Mundipharma Announce Completion of Phase 3 Trial of Rezafungin

GLOBENEWSWIRE

17 Aug 2021

Boyu, Sinopharm among bidders shortlisted for Mundipharma China -sources

Boyu, Sinopharm among bidders shortlisted for Mundipharma China -sources

Kane Wu REUTERS

08 Jun 2021

Mundipharma seeks bids for China unit in over $1 billion deal -sources

Mundipharma seeks bids for China unit in over $1 billion deal -sources

Kane Wu REUTERS

05 May 2021

Invasive candidiasis treatment rezafungin wins orphan drug status

Invasive candidiasis treatment rezafungin wins orphan drug status

Lucy Parsons PHARMATIMES

28 Jan 2021

Mundipharma and Cidara’s rezafungin gets Orphan Drug Designation in EU

Mundipharma and Cidara’s rezafungin gets Orphan Drug Designation in EU

PHARMACEUTICAL-TECHNOLOGY

27 Jan 2021

biophore-india-pharmaceuticals-pvt-ltd-m-2023-03-27

Access Virtual Booth

Contact Supplier

Send me more info on How To Grow My Business Digitally?

Market Place

Home

Menu

Post Enquiry

Market Place

Search